Literature DB >> 17479649

Magnetic resonance imaging of infantile hemangioendothelioma.

Ahmet Mesrur Halefoğlu1.   

Abstract

Infantile hemangioendothelioma is the most common benign hepatic tumor during infancy and also follows a benign course. During the routine physical examination of a 10-month-old female patient, masses of the liver were incidentally found. Laboratory studies revealed elevated liver function tests but normal alpha-fetoprotein level. Following the ultrasound (US) examination that demonstrated multiple hypoechoic liver masses, we performed magnetic resonance imaging (MRI) for further characterization of these lesions. Imaging features of the lesions were thought to be consistent with infantile hemangioendotheliomas especially based on dynamic post-contrast images. Although the patient's clinical condition was stable and she did not have any serious symptoms indicating congestive heart failure or coagulopathy, in terms of having a definitive diagnosis and ruling out a malignancy, a tru-cut liver biopsy was performed and histopathological examination confirmed the diagnosis.

Entities:  

Mesh:

Year:  2007        PMID: 17479649

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  3 in total

1.  Hepatic hemangioendothelioma of infancy: clinical features of a large cohort of patients and proposed management.

Authors:  Loredana Sana; Pietro Betalli; Michela Bravi; Paola Stroppa; Maurizio Cheli; Aurelio Sonzogni; Lisa Licini; Roberto Agazzi; Michele Colledan; Filippo Parolini; Daniele Alberti; Lorenzo D'Antiga
Journal:  Pediatr Surg Int       Date:  2021-01-29       Impact factor: 1.827

2.  Clinical features of infantile hepatic hemangioendothelioma.

Authors:  Eun Hee Kim; Kyung Nam Koh; Meerim Park; Bo Eun Kim; Ho Joon Im; Jong Jin Seo
Journal:  Korean J Pediatr       Date:  2011-06-30

3.  Diffuse Infantile Hepatic Hemangioendothelioma With Early Central Enhancement in an Adult: A Case Report of CT and MRI Findings.

Authors:  Aisheng Dong; Hui Dong; Changjing Zuo; Tianlin He
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.